Page 143 - MEMOCiberesp014-ENG

Most relevant scientific articles
• arCos D., BoCCaCCini a.r., Bohner M., Diez-Perez a., ePPle M., goMez-Barrena e . et al . The relevance of biomaterials to the prevention and treatment of osteoporosis . Acta Biomaterialia . 2014;10(5):1793- 1805 .
• siMMChen J., Baeza a., ruiz-Molina D., Vallet-regi M . Improving catalase-based propelled motor endu- rance by enzyme encapsulation . Nanoscale . 2014;6(15):8907-8913 .
• Mas n., arCos D., Polo l., aznar e., sanChez-salCeDo s., sanCenon F. et al . Towards the development of smart 3D “gated scaffolds” for on-command delivery . Small . 2014;10(23):4859-4864 .
• linares J., Matesanz M.C., Vila M., Feito M.J., gonCalVes g., Vallet-regi M. et al . Endocytic mechanisms of graphene oxide nanosheets in osteoblasts, hepatocytes and macrophages . ACS Applied Materials and Interfaces . 2014;6(16):13697-13706 .
• a. Baeza, e. guisasola, a. torres-ParDo, J.M. gonzÁlez-CalBet, g.J. Melen, M. raMirez, M. Vallet-regí. Hy- brid enzyme-polymeric capsules/mesoporous silica nanodevice for in situ cytotoxic agent generation . Adv . Funct . Mater . 24 (29), 4625-4633 (2014) .
Highlights
Institution: Universidad Complutense de Madrid Contact: Facultad de Farmacia . Ciudad Universitaria, s/n . 28040 Madrid · Tel .: (+34) 91 394 18 43 E-mail: vallet@ucm .es · Website: http://www .valletregigroup .com/
The most important achievements during 2014 include the design, optimization and implantation of 3D scaffolds based on bioceramics for bone tissue regeneration and the development of nanotechnological strategies to design smart drug delivery systems for antitumor therapy and infection treatment . During 2014, GIBI group has developed diverse research lines in the frame of different national research pro- jects including MAT2012-35556, MAT2013-43299-R and CSO2010-11384-E . GIBI group is member of the Research Institute of “Hospital 12 de Octubre (i+12)” and European Networking for prevention and treatment of osteoporotic fractures (www .agening .net) . GIBI group has also published18 original re- search articles, 2 patents, 4 book chapters, 1 complete book entitled “Bioceramics with Clinical Applica- tions” edited by María Vallet-Regí (John Wiley & Sons Limited, United Kingdom) and a total of 19 invited conferences in international research forums . Furthermore, the Thesis entitled “A new nanocomposite bioceramic for bone tissue regeneration” has been also disserted . In addition, GIBI group collaborates with many clinic institutions as Hospital Miguel Servet, Zaragoza, La Paz Hospital, Madrid, Alcalá de Henares University Hospital, Jimenez Diaz Foundation, Hospital del Mar Barcelona, University Hospital of Getafe, University Children’s Hospital Niño Jesus, Research Institute of Hospital 12 de Octubre (I+12) . Finally, the group has received the award IDEA2 (2014) with the Nanoimpant proyect .
http://mvisionconsortium .mit .edu/2014-idea%C2%B2-madrid-awardees-announced .
www .ciber-bbn .es 143